{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","spread":"4.49","value":"3.37"}]}],"title":"At study Enrollment"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"3.90","value":"2.30"}]}],"title":"At end of consolidation"}],"denoms":[{"counts":[{"groupId":"OG000","value":"29"}],"units":"Participants"}],"description":"Weight of unstimulated saliva production in grams.","dispersionType":"Standard Deviation","groups":[{"description":"AJCC Stage IIb - IV","id":"OG000","title":"Stratum II"}],"paramType":"MEAN","populationDescription":"Twenty-nine patients in stratum 2 were evaluated at both study enrollment and at the end of consolidation for the weight of unstimulated saliva production. This outcome measure was only collected for patients in Stratum 2.","reportingStatus":"POSTED","timeFrame":"At study enrollment","title":"Protective Effects of Amifostine Assessed Primarily by Sialometry: Weight of Unstimulated Saliva Production in Grams.","type":"SECONDARY","unitOfMeasure":"Grams of saliva"}